Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes

被引:45
作者
Mattonen, Sarah A. [1 ]
Palma, David A. [2 ]
Haasbeek, Cornelis J. A. [3 ]
Senan, Suresh [3 ]
Ward, Aaron D. [1 ]
机构
[1] Univ Western Ontario, Dept Med Biophys, London, ON, Canada
[2] London Reg Canc Program, Dept Radiat Oncol, London, ON, Canada
[3] Vrije Univ Amsterdam Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
关键词
BODY RADIOTHERAPY; LOCAL RECURRENCE; THERAPY; CARCINOMA; OUTCOMES; IMPACT;
D O I
10.3109/0284186X.2012.731525
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. For patients treated with stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer, benign computed tomography (CT) changes due to radiation-induced lung injury (RILI) can be difficult to differentiate from recurrence. We measured the utility of CT image feature analysis in differentiating RILI from recurrence, compared to Response Evaluation Criteria In Solid Tumours (RECIST). Materials and methods. Twenty-two patients with 24 lesions treated with SABR were selected (11 with recurrence, 13 with substantial RILI). On each follow-up CT, consolidative changes and ground glass opacities (GGO) were contoured. For each lesion, contoured regions were analysed for mean and variation in Hounsfield units (HU), 3D volume, and RECIST size during follow-up. Results. One hundred and thirty-six CT scans were reviewed, with a median imaging follow-up of 26 months. The 3D volume and RECIST measures of consolidative changes could significantly distinguish recurrence from RILI, but not until 15 months post-SABR; mean volume at 15 months [all values +/- 95% confidence interval (CI)] of 30.1 +/- 19.3 cm(3) vs. 5.1 +/- 3.6 cm(3) (p = 0.030) and mean RECIST size at 15 months of 4.34 +/- 1.13 cm vs. 2.63 +/- 0.84 cm (p = 0.028) respectively for recurrence vs. RILI. At nine months post-SABR, patients with recurrence had significantly higher-density consolidative changes (mean at nine months of -96.4 +/- 32.7 HU vs. -143.2 +/- 28.4 HU for RILI; p = 0.046). They also had increased variability of HU, an image texture metric, measured as the standard deviation (SD) of HU, in the GGO areas (SD at nine months of 210.6 +/- 14.5 HU vs. 175.1 +/- 18.7 HU for RILI; p = 0.0078). Conclusions. Quantitative changes in mean HU and GGO textural analysis have the potential to distinguish RILI from recurrence as early as nine months post-SABR, compared to 15 months with RECIST and 3D volume. If validated, this approach could allow for earlier detection and salvage of recurrence, and result in fewer unnecessary investigations of benign RILI.
引用
收藏
页码:910 / 918
页数:9
相关论文
共 25 条
[1]  
BYERS TE, 1984, JNCI-J NATL CANCER I, V72, P1271
[2]   Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer [J].
Dahele, Max ;
Palma, David ;
Lagerwaard, Frank ;
Slotman, Ben ;
Senan, Suresh .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :1221-1228
[3]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[4]   Fleischner Society:: Glossary of terms tor thoracic imaging [J].
Hansell, David M. ;
Bankier, Alexander A. ;
MacMahon, Heber ;
McLoud, Theresa C. ;
Mueller, Nestor L. ;
Remy, Jacques .
RADIOLOGY, 2008, 246 (03) :697-722
[5]   FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer [J].
Hoopes, David J. ;
Tann, Mark ;
Fletcher, James W. ;
Forquer, Jeffrey A. ;
Lin, Pei-Fen ;
Lo, Simon S. ;
Timmerman, Robert D. ;
McGarry, Ronald C. .
LUNG CANCER, 2007, 56 (02) :229-234
[6]   Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature [J].
Huang, Kitty ;
Dahele, Max ;
Senan, Suresh ;
Guckenberger, Matthias ;
Rodrigues, George B. ;
Ward, Aaron ;
Boldt, R. Gabriel ;
Palma, David A. .
RADIOTHERAPY AND ONCOLOGY, 2012, 102 (03) :335-342
[7]   Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma [J].
Kato, Satoshi ;
Nambu, Atsushi ;
Onishi, Hiroshi ;
Saito, Akitoshi ;
Kuriyama, Kengo ;
Komiyama, Takafumi ;
Marino, Kan ;
Araki, Tsutomu .
JAPANESE JOURNAL OF RADIOLOGY, 2010, 28 (04) :259-265
[8]   Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer [J].
Lagerwaard, Frank J. ;
Haasbeek, Cornelis J. A. ;
Smit, Egbert F. ;
Slotman, Ben J. ;
Senan, S. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (03) :685-692
[9]   Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer [J].
Lagerwaard, Frank J. ;
Verstegen, Naomi E. ;
Haasbeek, Cornelis J. A. ;
Slotman, Ben J. ;
Paul, Marinus A. ;
Smit, Egbert F. ;
Senan, Suresh .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01) :348-353
[10]   Reproducibility of spirometrically controlled CT lung densitometry in a clinical setting [J].
Lamers, RJS ;
Kemerink, GJ ;
Drent, M ;
van Engelshoven, JMA .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (04) :942-945